The German drug and pesticide evil Bayer ( the company who funded Adolph Hitler) who will need regulatory approval for their $66 billion plan to buy equally evil seed giant Monsanto, recently sat down for a meeting with president-elect Donald Trump. Speaking with Bayer Chief Executive Werner Baumann, Monsanto CEO Hugh Grant, and some other players in New York, the meeting was about the “future of agriculture” and “need for innovation.”
The meeting took place the day after Trump accused drug companies of “getting away with murder” for what they charge the government for medicines.
(To us, that sounds like putting small organic farmers out of business and making more Frankenfoods linked to cancer and autism. But, we shall see.)
This merger and that of Dow Chemical and DuPont will be decided by Trump’s future nominees to lead an antitrust enforcement at both the Justice Department and Federal Trade Commission.
If successful, the Bayer-Monsanto deal will see them controling 29 percent of the global seed market and a quarter of the global pesticide market.
From the article:
“Critics argue this dominant market position will allow it to crimp research and development efforts, but that’s just the start. While the company says the technique allows farmers in poorer nations see better harvests, many pro-organic consumers argue these crops carry significant health and environmental risks. Bayer has said that “much needed innovation will come from combined seeds-chemicals offerings and that it needs to merge to compete against other integrated suppliers such as the future Dow-Dupont’.”
Bayer, a spin-off of IG Farben who funded Hitler, is among the world’s top 20 pharmaceutical groups, with products like the dangerous Yasmin birth-control pills and stroke prevention drug, Xarelto. The billions they net in profit do little to make up for the countless victims who have died from taking the prescribed doses of their dangerous and often deadly drugs.
Souce: Reuters
